Teo Dagi, MD

  • Partner, HLM Venture Partners, Boston, MA

    Prior to joining HLM in 2006, Teo was a Managing Partner of Cordova Ventures in Atlanta and oversaw its life sciences and health care portfolio. Before joining Cordova Ventures, Teo served as Principal at Access Partners in Westport, CT. Prior to that, he taught and practiced neurosurgery on the faculties of Harvard, Brown and Georgetown Universities, the Uniformed Services University of the Health Sciences and the National Institutes of Health. Teo currently serves as a director of IntelliDx and was previously a director of 14 publicly traded and privately held companies including: Atherogenics, Argos Therapeutics, Axela Biosensors and Inhibitex. He also is on the advisory board of Vengrowth, Oxford Finance Corporation, and sits on the steering committee of the Program in Biomedical Entrepreneurship of the Massachusetts Institute of Technology. Teo received an AB from Columbia College, an MD and MPH from Johns Hopkins, an MTS from Harvard, where he was a Joseph P. Kennedy, Jr. Fellow, and an MBA with distinction from the Wharton School. He trained in neurosurgery at the Massachusetts General Hospital and is a diplomat of the American Board of Neurological Surgeons.

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!